Denali Therapeutics Exercises Option to Acquire F-Star Gamma
By Natasha Piper
Pharma Deals Review: Vol 2018 Issue 6 (Table of Contents)
Published: 28 Jun-2018
DOI: 10.3833/pdr.v2018.i6.2332 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Committed to defeating neurogenerative disease, Denali Therapeutics has exercised an option to acquire F-Star Gamma for US$24 M as well as potential milestone payments of up to US$447 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS